Ocata Therapeutics Inc fka OCAT

[elichen]

There's a good chance ACTC will receive fast-track authorization to commercialize their treatment--the same treatment that worked so fabulously in the clinical trials.

No safety issues and significant improvement in visual acuity, even though that was not being tested for.

The pps is not relevant at this time--except that it's easy to accumulate at these levels. One day out of the blue--whammo--it will start running up with unstoppabe momentum!